Merve Cakir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Merve Cakir has a total of 587 co-authors. Here are the top co-authors by number of shared publications:
- Beril Tutuncuoglu
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA
9 shared publications - Manon Eckhardt
Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA, USA
8 shared publications - Nevan J. Krogan
Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94158, USA
8 shared publications - Kris C. Wood
Department of Pharmacology and Cancer Biology, Duke University, Durham, USA
6 shared publications - Danielle L. Swaney
University of California, San Francisco
5 shared publications David E. Gordon
5 shared publications
Latest Publications
- Top Cited Papers
- 27 August 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6814)
Autism mutations rewire protein interaction networks to drive neurodevelopmental pathology
Systematic mapping of protein-protein interaction (PPI) networks and determining how causal mutations rewire them in autism spectrum disorder (ASD) provide a powerful framework for uncovering disease mechanisms and therapeutic opportunities. Using affinity purification–mass spectrometry, we systematically mapped PPIs for 100 high-confidence ASD genes, uncovering more than 1800 interactions. By assessing the impact of pathogenic missense mutations, leveraging AlphaFold, and validating key findings in human-derived model systems, we identified marked convergence onto shared protein complexes in the wild-type state and convergent PPI rewiring driven by independent mutations. For example, distinct patient-derived variants in FOXP1 disrupt its interactions with FOXP4, leading to changes in cortical neurogenesis and neural activity in brain organoids. Overall, these findings link genetic variation to protein networks and convergent neurodevelopmental dysfunction in ASD.
- 27 August 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6814)
Top Cited PapersAutism mutations rewire protein interaction networks to drive neurodevelopmental pathology
Systematic mapping of protein-protein interaction (PPI) networks and determining how causal mutations rewire them in autism spectrum disorder (ASD) provide a powerful framework for uncovering disease mechanisms and therapeutic opportunities. Using affinity purification–mass spectrometry, we systematically mapped PPIs for 100 high-confidence ASD genes, uncovering more than 1800 interactions. By assessing the impact of pathogenic missense mutations, leveraging AlphaFold, and validating key findings in human-derived model systems, we identified marked convergence onto shared protein complexes in the wild-type state and convergent PPI rewiring driven by independent mutations. For example, distinct patient-derived variants in FOXP1 disrupt its interactions with FOXP4, leading to changes in cortical neurogenesis and neural activity in brain organoids. Overall, these findings link genetic variation to protein networks and convergent neurodevelopmental dysfunction in ASD.
- Open Access
- 30 June 2026
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 22 (6) , e1012204
Genetic survey of biomarkers at early and mid-pregnancy identifies pregnancy-specialized immune regulation
Much remains unknown about the genetics of immune system changes during pregnancy. We used SNP data in a pregnancy cohort to genetically investigate 47 immune biomarkers at two timepoints, along with change between timepoints (Δ). We identified 19 biomarkers with significant SNP-based heritability and 34 with genome-wide significant signals, demonstrating genetic regulation. The same biomarkers measured in early- and mid-pregnancy shared about half of significant associations across timepoints, with enrichment for immune pathways. In contrast, Δ showed enrichment in transcription factors and developmental processes. About half of suggestive associations overlapped with non-pregnancy associations. However, these data leave a substantial fraction of potentially timepoint-specific and pregnancy-unique findings. Nearby genes were enriched for high expression in decidual cells at the maternal-fetal interface, reinforcing the novelty of our results. We additionally explored the relationship between immune genetic associations and prior GWAS of pregnancy complications. Overall, we present the first two-timepoint genetic study of immune profile in pregnancy.
- 30 June 2026
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 22 (6) , e1012204
Open AccessGenetic survey of biomarkers at early and mid-pregnancy identifies pregnancy-specialized immune regulation
Much remains unknown about the genetics of immune system changes during pregnancy. We used SNP data in a pregnancy cohort to genetically investigate 47 immune biomarkers at two timepoints, along with change between timepoints (Δ). We identified 19 biomarkers with significant SNP-based heritability and 34 with genome-wide significant signals, demonstrating genetic regulation. The same biomarkers measured in early- and mid-pregnancy shared about half of significant associations across timepoints, with enrichment for immune pathways. In contrast, Δ showed enrichment in transcription factors and developmental processes. About half of suggestive associations overlapped with non-pregnancy associations. However, these data leave a substantial fraction of potentially timepoint-specific and pregnancy-unique findings. Nearby genes were enriched for high expression in decidual cells at the maternal-fetal interface, reinforcing the novelty of our results. We additionally explored the relationship between immune genetic associations and prior GWAS of pregnancy complications. Overall, we present the first two-timepoint genetic study of immune profile in pregnancy.
- Open Access
Genetic survey of biomarkers across pregnancy identifies pregnancy-specialized immune regulation
Much remains unknown about the genetics of immune system changes during pregnancy. We used SNP data in a pregnancy cohort to genetically investigate 47 immune biomarkers at two timepoints, along with change between timepoints (delta). We identified 19 biomarkers with significant SNP-based heritability and 34 with genome-wide significant signals, demonstrating genetic regulation. The same biomarkers measured in early- and mid-pregnancy shared about half of significant associations across timepoints, with enrichment for immune pathways. In contrast, delta showed enrichment in transcription factors and developmental processes. About half of suggestive associations overlapped with non-pregnancy associations. However, these data leave a substantial fraction of potentially timepoint-specific and pregnancy-unique findings. Nearby genes were enriched for placental expression, reinforcing the novelty of our results. We additionally explored the relationship between immune genetic associations and prior GWAS of pregnancy complications. Overall, we present the first multi-timepoint genetic study of immune profile in pregnancy.
Open AccessGenetic survey of biomarkers across pregnancy identifies pregnancy-specialized immune regulation
Much remains unknown about the genetics of immune system changes during pregnancy. We used SNP data in a pregnancy cohort to genetically investigate 47 immune biomarkers at two timepoints, along with change between timepoints (delta). We identified 19 biomarkers with significant SNP-based heritability and 34 with genome-wide significant signals, demonstrating genetic regulation. The same biomarkers measured in early- and mid-pregnancy shared about half of significant associations across timepoints, with enrichment for immune pathways. In contrast, delta showed enrichment in transcription factors and developmental processes. About half of suggestive associations overlapped with non-pregnancy associations. However, these data leave a substantial fraction of potentially timepoint-specific and pregnancy-unique findings. Nearby genes were enriched for placental expression, reinforcing the novelty of our results. We additionally explored the relationship between immune genetic associations and prior GWAS of pregnancy complications. Overall, we present the first multi-timepoint genetic study of immune profile in pregnancy.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Data from The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2
Summary:The mapping of SARS-CoV-2 human protein–protein interactions by Gordon and colleagues revealed druggable targets that are hijacked by the virus. Here, we highlight several oncogenic pathways identified at the host–virus interface of SARS-CoV-2 to enable cancer biologists to apply their knowledge for rapid drug repurposing to treat COVID-19, and help inform the response to potential long-term complications of the disease.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2
Summary:The mapping of SARS-CoV-2 human protein–protein interactions by Gordon and colleagues revealed druggable targets that are hijacked by the virus. Here, we highlight several oncogenic pathways identified at the host–virus interface of SARS-CoV-2 to enable cancer biologists to apply their knowledge for rapid drug repurposing to treat COVID-19, and help inform the response to potential long-term complications of the disease.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S1 from The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2
Cancer drugs targeting the identified virus-host protein-protein interactions of SARS-CoV-2
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2
Cancer drugs targeting the identified virus-host protein-protein interactions of SARS-CoV-2
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S1 from The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2
Cancer drugs targeting the identified virus-host protein-protein interactions of SARS-CoV-2
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2
Cancer drugs targeting the identified virus-host protein-protein interactions of SARS-CoV-2
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Data from The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2
Summary:The mapping of SARS-CoV-2 human protein–protein interactions by Gordon and colleagues revealed druggable targets that are hijacked by the virus. Here, we highlight several oncogenic pathways identified at the host–virus interface of SARS-CoV-2 to enable cancer biologists to apply their knowledge for rapid drug repurposing to treat COVID-19, and help inform the response to potential long-term complications of the disease.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2
Summary:The mapping of SARS-CoV-2 human protein–protein interactions by Gordon and colleagues revealed druggable targets that are hijacked by the virus. Here, we highlight several oncogenic pathways identified at the host–virus interface of SARS-CoV-2 to enable cancer biologists to apply their knowledge for rapid drug repurposing to treat COVID-19, and help inform the response to potential long-term complications of the disease.
- Top Cited PapersOpen Access
- 4 December 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 370 (6521) , 1181-+
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
How lethal coronaviruses engage hosts: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is closely related to the deadly coronaviruses SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV). Considerable efforts are focused on developing treatments, and therapies that work across coronaviruses would be particularly valuable. Shedding light on the host factors hijacked by the viruses, Gordon et al. mapped the interactions between viral and human proteins for SARS-CoV-2, SARS-CoV-1, and MERS-CoV; analyzed the localization of viral proteins in human cells; and used genetic screening to identify host factors that either enhance or inhibit viral infection. For a subset of the interactions essential for the virus life cycle, the authors determined the cryo–electron microscopy structures and mined patient data to understand how targeting host factors may be relevant to clinical outcomes. Science , this issue p. eabe9403
- 4 December 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 370 (6521) , 1181-+
Top Cited PapersOpen AccessComparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
How lethal coronaviruses engage hosts: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is closely related to the deadly coronaviruses SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV). Considerable efforts are focused on developing treatments, and therapies that work across coronaviruses would be particularly valuable. Shedding light on the host factors hijacked by the viruses, Gordon et al. mapped the interactions between viral and human proteins for SARS-CoV-2, SARS-CoV-1, and MERS-CoV; analyzed the localization of viral proteins in human cells; and used genetic screening to identify host factors that either enhance or inhibit viral infection. For a subset of the interactions essential for the virus life cycle, the authors determined the cryo–electron microscopy structures and mined patient data to understand how targeting host factors may be relevant to clinical outcomes. Science , this issue p. eabe9403
- Top Cited Papers
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
- Open Access
- 1 July 2020
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 10 (7) , 916-921
The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2
Summary: The mapping of SARS-CoV-2 human protein–protein interactions by Gordon and colleagues revealed druggable targets that are hijacked by the virus. Here, we highlight several oncogenic pathways identified at the host–virus interface of SARS-CoV-2 to enable cancer biologists to apply their knowledge for rapid drug repurposing to treat COVID-19, and help inform the response to potential long-term complications of the disease.
- 1 July 2020
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 10 (7) , 916-921
Open AccessThe Landscape of Human Cancer Proteins Targeted by SARS-CoV-2
Summary: The mapping of SARS-CoV-2 human protein–protein interactions by Gordon and colleagues revealed druggable targets that are hijacked by the virus. Here, we highlight several oncogenic pathways identified at the host–virus interface of SARS-CoV-2 to enable cancer biologists to apply their knowledge for rapid drug repurposing to treat COVID-19, and help inform the response to potential long-term complications of the disease.